Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Leukemia
|
April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy
Gloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Blood
|
February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Science Translational Medicine
|
July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis
Alexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Claire Roddie, Juliana Dias, Maeve A O'Reilly, et al.
Blood
|
September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
Michael A Chapman, Jonathan Sive, John Ambrose, et al.
Blood Advances
|
March 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma
Andrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Journal of Hepatology
|
August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Tim Meyer, Richard S Finn, Mitesh Borad, et al.
Cancer Cell
|
March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
The New England Journal of Medicine
|
November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
Claire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.
Blood Cancer Journal
|
April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Leukemia
|
April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy
Gloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Blood
|
February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
Claire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Science Translational Medicine
|
July 1, 2026
CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis
Alexandros Rampotas, Zoë C Wong, Isaac Gannon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2021
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Claire Roddie, Juliana Dias, Maeve A O'Reilly, et al.
Blood
|
September 6, 2018
RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature
Michael A Chapman, Jonathan Sive, John Ambrose, et al.
Blood Advances
|
March 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma
Andrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Journal of Hepatology
|
August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Tim Meyer, Richard S Finn, Mitesh Borad, et al.
Cancer Cell
|
March 27, 2018
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
Frederick Arce Vargas, Andrew J S Furness, Kevin Litchfield, et al.
The New England Journal of Medicine
|
November 27, 2024
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
Claire Roddie, Karamjeet S Sandhu, Eleni Tholouli, et al.
Blood Cancer Journal
|
April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.
Page
of 7